Botulinum toxin in headache;Toxine botulique et céphalées

Annales de Readaptation et de Medecine Physique

Volumn 46, Issue 6, 2003, Pages 312-318

  Simon, O ^a   Raibaut, P ^a   Faucher, M ^a   Sheik Ismael, S ^a   Amarenco, G ^a  

^a HÔPITAL ROTHSCHILD   (France)

Author keywords

Botulinum toxine; Frontal tension headache; Headache; Migraine

Indexed keywords

BOTULINUM TOXIN;

DRUG EFFECT; DRUG MECHANISM; DRUG USE; HEADACHE; HUMAN; PAIN; PATHOPHYSIOLOGY; REVIEW;

EID: 0041928186     PISSN: 01686054     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-6054(03)00104-1     Document Type: Article

References (49)

1. Aoki R. The development of Botox - its history and pharmacology. Pain Digest 1998;8:337-41.
2. Benecke R, Hagenah R, Wiegand H. Effects of type A botulinum toxin on some synaptic transmissions in the spinal cord of cats. Pflüglers Arch 1975;359:90.
3. Binder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM. Botulinum toxin type A (Botox) for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg 2000;123:669-76.
4. Brin MF, Fahn S, Moskowitz C, Friedman A, Shale HM, Greene PE, et al. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord 1987;24:237-54.
5. Brin MF, Swope DM, O'Brian C, Abbasi S, Pogoda JM. Botox(r) for migraine: double-blind, placebo-controlled, region-specific evaluation. Cephalalgia 2000;20:421-2.
6. Burch CM, Kokoska MS, Glaser DA, Hollenbeak CS. Treatment of frontal tension headaches with botulinum toxin A. Cephalalgia 2001;21:486-91.
7. Cui M, Aoki KR. Botulinum toxin A (BTX-a) reduces inflammatory pain in the rat formalin model. Cephalalgia 2000;20:414.
8. Evers S, Rahmann A, Vollmer-Haase J, Husstedt IW. Treatment of headache with botulinum toxin A- A review according to evidence-based medicine criteria. Cephalalgia 2002;22:699-710.
9. Filippi GM, Errico P, Santarelli R, Bagolini B, Manni E. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol 1993;113(3):400-4.
10. Freund BJ, Schwartz M. The use of botulinum toxin-A in the treatment of refractory cluster headache: case reports. Cephalalgia 2000;20:329-30.
11. Freund BJ, Schwartz M. Treatment of chronic cervical-associated headache with botulinum toxin A: a pilot study. Headache 2000;40:231-6.
12. Giladi N. The mechanism of action of botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site. J Neurol Sci 1997;152(2):132-5.
13. Göbel H, Deuschl G. Dauerkontraktionen kranialer oder zervikaler muskeln - wenn dystonien kopfschmerz bereiten. Münch Med Wschr 1999;139:30-1.
14. Gobel H, Heinze A, Heinze-Kuhn K, Austermann K. Botulinum toxin A for the treatment of headache disorders and pericranial pain syndromes. Nervenarzt 2001;72(4):261-74.
15. Göbel H, Lindner V, Krack P, Heinze A, Gaartz N, Deuschl G. Treatment of chronic tension-type headache with botulinum toxin. Cephalalgia 1999;19:455.
16. Greene P, Kang U, Fahn S, Brin M, Moskowitz C, Flaster E. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology 1990;40:1213-8.
17. Guyer BM. Mechanism of botulinum toxin in the relief of chronic pain. Curr Rev Pain 1999;3:427-31.
18. Hagenah R, Benecke R, Wiegand H. Effects of type A botulinum toxin on the cholinergic transmission at spinal Renshaw cells and on the inhibitory action at Ia inhibitory interneurones. Naunyn Schmiedebergs Arch Pharmacol 1977;299(3):267-72.
19. Hobson DE, Gladish DF. Botulinum toxin injection for cervicogenic headache. Headache 1997;37:253-5.
20. Humm AM, Pabst C, Lauterburg T, Burgunder JM. Enkephalin and aFGF are differentially regulated in rat spinal motoneurons after chemodenervation with botulinum toxin. Exp Neurol 2000;161:361-72.
21. Ishikawa H, Mitsui Y, Yoshitomi T, Mashimo K, Aoki S, Mukuno K, et al. Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles. Jpn J Ophthalmol 2000;44:106-9.
22. Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology 1990;40:277-80.
23. Klapper JA, Mathew NT, Klapper A, Kailasam J. Botulinum toxin type A (BTX-A) for the prophylaxis of chronic daily headache. Cephalalgia 2000;20:292-3.
24. Mauskop A. Botulinum toxin in the treatment of chronic daily headaches. Cephalalgia 1999;19:453.
25. Mauskop A, Basdeo R. Botulinum toxin A is an effective prophylactic therapy for migraines. Cephalalgia 2000;20:422.
26. Porta M. A comparative trial of botulinum toxin type A and methyl-prednisolone for the treatment of tension-type headache. Curr Rev Pain 2000;4:31-5.
27. Purkiss JR, Welch MJ, Doward S, Foster KA. Capsaicin stimulates release of substance P from dorsal root ganglion neurons via two distinct mechanisms. Biochem Soc Trans 1997;25:542.
28. Relja M. Treatment of tension-type headache by local injection of botulinum toxin. Eur J Neurol 1997;4(Suppl. 2):71-3.
29. Relja M. Treatment of tension-type headache with botulinum toxin: 1-year follow-up. Cephalalgia 2000;20:336.
30. Relja MA, Klepac N. Botulinum toxin A as prophylactic treatment in chronic tension-type headache: long-term follow-up study. Neurology 2001;56(Suppl. 3):A349-50.
31. Robbins L. Botulinum toxin A for refractory chronic daily headache. Neurology 2001;56(Suppl. 3):A349.
32. Robbins L. Botulinum toxin A (Botox) for cluster headache: 6 cases. Cephalalgia 2000;21:499-500.
33. Rollnik JD, Karst M, Fink M, Dengler R. Botulinum toxin type A and EMG: a key to the understanding of chronic tension-type headaches? Headache 2002;41:985-9.
34. Rollnik JD, Tanneberger O, Schubert M, Schneider U, Dengler R. Treatment of tension-type headache with botulinum toxin A: a double-blind, placebo-controlled study. Headache 2000;40:300-5.
35. Rosales RL, Arimura K, Takenaga S, Osame M. Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve 1996;19:488-96.
36. Schmitt WJ, Slowey E, Fravi N, Weber S, Burgunder JM. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache 2001;41:658-64.
37. Schnider P, Moraru E, Bittner C, Vigl M, Wöber C, Maly J, et al. Physical therapy and botulinum toxin type A in patients with cervical associated headache according to HIS criteria: double-blind placebo-controlled study. Neurology 2001;56(Suppl. 3):A349.
38. Schulte-Mattler WJ, Wieser T, Zierz S. Treatment of tension-type headache with botulinum toxin: a pilot study. Eur J Med Res 1999;4:183-6.
39. Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin type A as a migraine preventive treatment. Headache 2000;40:445-50.
40. Sjaastad O, Fredriksen TA, Pfaffenrath V. Cervicogenic headache: diagnostic criteria. Headache 1998;38:442-5.
41. Smuts JA, Baker MK, Smuts HM, Stassen JMR, Roussouw E, Barnard PWA. Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Eur J Neurol 1999;6(Suppl. 4):99-102.
42. Smuts JA, Barnard PWA. Botulinum toxin type A in the treatment of headache syndromes: a clinical report on 79 patients. Cephalalgia 2000;20:332-7.
43. Travell JG, Simons DG. The trigger point manual. Baltimore, MD: Williams & Wilkins,; 1993.
44. Van den Bergh P, De Beukelaer M, Deconinck N. Effect of muscle denervation on the expression of substance P in the ventral raphespinal pathway of the rat. Brain Res 1996;707:206-12.
45. Weiller C, May A, Limmroth V, Juptner M, Kaube H, Schayck RV, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995;17:658-60.
46. Wheeler AH. Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension. Headache 1998;38:468-71.
47. Wiegand H, Erdmann G, Wellhoner HH. 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol 1976;292:161-5.
48. Wiegand H, Wellhoner HH. The action of botulinum A neurotoxin on the inhibition by antidromic stimulation of the lumbar monosynaptic reflex. Naunyn Schmiedebergs Arch Pharmacol 1977;298:235-8.
49. Zwart JA, Bovim G, Sand T, Sjaastad O. Tension headache: botulinum toxin paralysis of temporal muscles. Headache 1994;34:458-62.